Browse studies
Find your next paid study
2 recruiting studies matching your filters
Observational
Testing the Feasibility and Acceptability of a Remotely Delivered Program to Promote Active Living Among People With Metastatic Breast Cancer
Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activit…
Metastatic Invasive Breast Cancer
Estimated
~$10 – $6,250
University of OklahomaNCT07238023
Phase 2
Neu Direction: A Single Center Phase II Randomized Clinical Trial to Assess the Efficacy of Adding HER Inhibition to Standard of Care in Patients With Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
The goal of this clinical trial is to learn if neratinib, an FDA-approved oral pan-HER2/3/4 inhibitor, improves disease control for participants with metastati…
Metastatic Invasive Breast CancerResistant Breast CancerER+, HER2-, Metastatic Breast Cancer
Estimated
~$10 – $6,250
University of California, San DiegoNCT07729046